India · Delayed Price · Currency is INR Zydus Wellness Statistics
Total Valuation
Zydus Wellness has a market cap or net worth of INR 191.64 billion. The enterprise value is 222.52 billion.
| Market Cap | 191.64B |
| Enterprise Value | 222.52B |
Important Dates
The next confirmed earnings date is Tuesday, August 4, 2026.
| Earnings Date | Aug 4, 2026 |
| Ex-Dividend Date | Jul 17, 2026 |
Share Statistics
| Current Share Class | 318.16M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -0.29% |
| Owned by Insiders (%) | 0.97% |
| Owned by Institutions (%) | 22.51% |
| Float | 93.08M |
Valuation Ratios
The trailing PE ratio is 97.18 and the forward PE ratio is 43.49.
| PE Ratio | 97.18 |
| Forward PE | 43.49 |
| PS Ratio | 4.84 |
| PB Ratio | 3.29 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 153.68 |
| P/OCF Ratio | 84.65 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 44.49, with an EV/FCF ratio of 178.45.
| EV / Earnings | 112.84 |
| EV / Sales | 5.62 |
| EV / EBITDA | 44.49 |
| EV / EBIT | 62.56 |
| EV / FCF | 178.45 |
Financial Position
The company has a current ratio of 1.88, with a Debt / Equity ratio of 0.55.
| Current Ratio | 1.88 |
| Quick Ratio | 0.75 |
| Debt / Equity | 0.55 |
| Debt / EBITDA | 6.40 |
| Debt / FCF | 25.68 |
| Interest Coverage | 3.74 |
Financial Efficiency
Return on equity (ROE) is 3.43% and return on invested capital (ROIC) is 3.48%.
| Return on Equity (ROE) | 3.43% |
| Return on Assets (ROA) | 2.65% |
| Return on Invested Capital (ROIC) | 3.48% |
| Return on Capital Employed (ROCE) | 3.71% |
| Weighted Average Cost of Capital (WACC) | 3.60% |
| Revenue Per Employee | 23.51M |
| Profits Per Employee | 1.17M |
| Employee Count | 1,247 |
| Asset Turnover | 0.47 |
| Inventory Turnover | 2.44 |
Taxes
In the past 12 months, Zydus Wellness has paid 333.00 million in taxes.
| Income Tax | 333.00M |
| Effective Tax Rate | 14.45% |
Stock Price Statistics
The stock price has increased by +43.86% in the last 52 weeks. The beta is -0.09, so Zydus Wellness's price volatility has been lower than the market average.
| Beta (5Y) | -0.09 |
| 52-Week Price Change | +43.86% |
| 50-Day Moving Average | 530.45 |
| 200-Day Moving Average | 466.28 |
| Relative Strength Index (RSI) | 62.68 |
| Average Volume (20 Days) | 1,508,223 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Zydus Wellness had revenue of INR 39.61 billion and earned 1.97 billion in profits. Earnings per share was 6.20.
| Revenue | 39.61B |
| Gross Profit | 23.71B |
| Operating Income | 3.56B |
| Pretax Income | 2.31B |
| Net Income | 1.97B |
| EBITDA | 4.98B |
| EBIT | 3.56B |
| Earnings Per Share (EPS) | 6.20 |
Balance Sheet
The company has 1.15 billion in cash and 32.03 billion in debt, with a net cash position of -30.88 billion.
| Cash & Cash Equivalents | 1.15B |
| Total Debt | 32.03B |
| Net Cash | -30.88B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 58.26B |
| Book Value Per Share | 183.11 |
| Working Capital | 6.38B |
Cash Flow
In the last 12 months, operating cash flow was 2.26 billion and capital expenditures -1.02 billion, giving a free cash flow of 1.25 billion.
| Operating Cash Flow | 2.26B |
| Capital Expenditures | -1.02B |
| Depreciation & Amortization | 1.42B |
| Net Borrowing | 28.23B |
| Free Cash Flow | 1.25B |
| FCF Per Share | n/a |
Margins
Gross margin is 59.86%, with operating and profit margins of 8.98% and 4.98%.
| Gross Margin | 59.86% |
| Operating Margin | 8.98% |
| Pretax Margin | 5.82% |
| Profit Margin | 4.98% |
| EBITDA Margin | 12.57% |
| EBIT Margin | 8.98% |
| FCF Margin | 3.15% |
Dividends & Yields
This stock pays an annual dividend of 1.20, which amounts to a dividend yield of 0.20%.
| Dividend Per Share | 1.20 |
| Dividend Yield | 0.20% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | 19.37% |
| Buyback Yield | n/a |
| Shareholder Yield | 0.20% |
| Earnings Yield | 1.03% |
| FCF Yield | 0.65% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for Zydus Wellness is 573.57, which is -4.48% lower than the current price. The consensus rating is "Buy".
| Price Target | 573.57 |
| Price Target Difference | -4.48% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (3Y) | 20.43% |
| EPS Growth Forecast (3Y) | 48.44% |
Stock Splits
The last stock split was on September 18, 2025. It was a forward split with a ratio of 5.
| Last Split Date | Sep 18, 2025 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
Zydus Wellness has an Altman Z-Score of 2.66 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.66 |
| Piotroski F-Score | 7 |